MedPath

To study how Ripasudil can help for graft survival after corneal transplant

Phase 4
Not yet recruiting
Conditions
Health Condition 1: H179- Unspecified corneal scar and opacity
Registration Number
CTRI/2024/06/069429
Lead Sponsor
Malvika Gokhale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients who will undergo Penetrating Keratoplasty at Sankara Eye Hospital, Bangalore

Exclusion Criteria

1. Re-grafts

2. High risk grafts- Viral keratitis, Highly vascularized grafts

3. Pregnant women, Lactating mothers

4. Any posterior segment diseases

5. one eyed patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.